Banerjee R, Hersh AL, Newland J, et al; on behalf of the Emerging Infections Network Hemolytic-Uremic Syndrome Study Group Most (92%) of the cases were confirmed by culture with the remaining 8% being ... Healio: Ravulizumab improves kidney function in patients with atypical hemolytic uremic syndrome Healio: Real-world data confirm benefits of ravulizumab for atypical hemolytic uremic syndrome Hemolytic uremic syndrome, also called HUS, is a condition that can happen when small blood vessels become damaged and inflamed. This damage can cause clots to form in the vessels all through the body.

Understanding the Context

This activity describes the evaluation of hemolytic uremic syndrome and how to differentiate HUS from other forms of thrombotic microangiopathies. The differing etiologies of HUS, varying clinical presentations, and cellular pathways are reviewed. In the 1980s, Mohamed Karmali (1945–2016) was the first to make the association between Stx, diarrheal E. coli infection and the (then considered) idiopathic hemolytic uremic syndrome of infancy and childhood.

Key Insights

Hemolytic uremic syndrome (HUS) is a condition that damages blood vessels in your kidneys. E. coli infection is the most common cause of HUS. In most cases, symptoms include diarrhea, abdominal pain, high blood pressure and peeing less than usual. Treatment includes transfusions and medications.

Final Thoughts

Detailed information on hemolytic uremic syndrome, including cause, progression, treatment, and statistics Hemolytic uremic syndrome (HUS) is a condition that affects the blood and blood vessels. It results in the destruction of blood platelets (cells involved in clotting), a low red blood cell count (anemia) and kidney failure due to damage to the very small blood vessels of the kidneys. Hemolytic uremic syndrome (HUS) is very serious complication of Shiga toxin-producing E. coli (STEC) infection. It can lead to kidney failure, permanent health problems, and even death. The hemolytic-uremic syndrome (HUS) has been recognized for more than 45 years and consists of the combination of hemolytic anemia, thrombocytopenia, and acute renal failure.

Hemolytic-Uremic Syndrome (HUS) - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the Merck Manuals - Medical Professional Version. Hemolytic-Uremic Syndrome (HUS) - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical Professional Version.